Professional Design Tangeretin - Cytisine – Chenlv Detail:
CAS No.: 485-35 -8
Latin name: genera Laburnum, Cytisus
Part used: whole herb
Appearance: off-white to yellowish-brown crystalline solid
Test method: HPLC
Specification: 98%
Cytisine is an alkaloid naturally derived from the Fabaceae family of plants including the genera Laburnum and Cytisus. Recent studies have shown it to be a more effective and significantly more affordable smoking cessation treatment than nicotine replacement therapy. Also known as baptitoxine or sophorine, cytisine has been used as a smoking cessation treatment since 1964, and is relatively unknown in regions outside of central and Eastern Europe. Cytisine is a partial nicotinic acetylcholine agonist with a half-life of 4.8 hours. Recent Phase III clinical trials using Tabex (a brand of Cytisine marketed by Sopharma AD) have shown similar efficacy to varenicline, but at a fraction of the cost.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
Bear "Customer first, High quality first" in mind, we perform closely with our consumers and provide them with efficient and experienced services for Professional Design Tangeretin - Cytisine – Chenlv, The product will supply to all over the world, such as: Swiss , Argentina , Cologne , Taking the core concept of "to be the Responsible". We'll redound up on society for high quality merchandise and good service. We will initiative to participate in international competition to be a first- class manufacturer of this product in the world.
By Daphne
from Bangalore
- 2018.12.05 13:53
As an international trading company, we have numerous partners, but about your company, I just want to say, you are really good, wide range, good quality, reasonable prices, warm and thoughtful service, advanced technology and equipment and workers have professional training, feedback and product update is timely, in short, this is a very pleasant cooperation, and we look forward to the next cooperation!
By Murray
from Paris
- 2017.11.12 12:31